Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | PKM | P14618 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.48 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.47 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.47 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.47 |
| ▸ | HPGDS | O60760 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23205340 | 0.83 | RAB9A (0.52) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL31146981 | 0.78 | SMARCA2 (0.61) | RAB9APKMMAPTALDH1A1MEN1 | |
| SCHEMBL1752788 | 0.78 | ADORA2A (0.49) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL30962961 | 0.78 | CASP1 (0.53) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL1752783 | 0.78 | SMARCA2 (0.66) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL1752894 | 0.78 | LDHA (0.50) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL6744620 | 0.78 | RAB9A (0.47) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL1752868 | 0.78 | PDE10A (0.47) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL1752814 | 0.78 | RAB9A (0.47) | RAB9APKMMAPTALDH1A1KDM4E | |
| SCHEMBL10834971 | 0.78 | RAB9A (0.47) | RAB9APKMMAPTALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454042-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2019-10-22 | — | — | US | disclosed |
| US-20160079545-A1 | Organic Electroluminescence Device | UDC Ireland (IE) | 2016-03-17 | — | — | US | disclosed |
| US-9287515-B2 | Compositions comprising organic and organometallic compounds, and their applications in organic electroluminescence, light emission, display, and illumination devices | UDC Ireland (IE) | 2016-03-15 | — | — | US | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120302581-A1 | Methods and Compositions for the Treatment of RAS Associated Disorders | THE TRUSTEES OF DARTMOUTH COLLEGE | 2012-11-29 | — | — | US | disclosed |
| US-20120302581-A1 | Methods and Compositions for the Treatment of RAS Associated Disorders | THE TRUSTEES OF DARTMOUTH COLLEGE | 2012-11-29 | — | — | US | disclosed |
| US-20120153272-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120153272-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| CN-102292826-A | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | — | 2011-12-21 | — | — | CN | disclosed |
| EP-2380208-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. du Pont de Nemours and Company (US) | 2011-10-26 | — | — | EP | disclosed |
| US-7993760-B2 | Compound for use in organic electroluminescent device and organic electroluminescent device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7993760-B2 | Compound for use in organic electroluminescent device and organic electroluminescent device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| WO-2010085664-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| US-20090302742-A1 | Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090302742-A1 | Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device | LAGE3, ICMT, PPOX | RAB9A 2408/4885PKM 720/4885MAPT 445/4885 |
| US-10454042-B2 | Organic electroluminescence device | EML4, ELOC, ORC3 | RAB9A 3982/4885PKM 2588/4885MAPT 503/4885 |
| US-20120302581-A1 | Methods and Compositions for the Treatment of RAS Associated Disorders | NRAS, HRAS, KRAS | RAB9A 596/4885PKM 4547/4885MAPT 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.